Click for best price
Antiinflammatory Therapeutics Market Size, Share 2023
| Market size in 2022 |
US$ 113740 million
|
Forecast Market size by 2029 |
US$ 169200 million
|
| Growth Rate |
CAGR of 5.8% |
Number of Pages |
62 Pages |
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Therapeutics. This report contains market size and forecasts of Anti-inflammatory Therapeutics in global, including the following market information:
Global Anti-inflammatory Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Anti-inflammatory Therapeutics market was valued at US$ 113740 million in 2022 and is projected to reach US$ 169200 million by 2029, at a CAGR of 5.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
We surveyed the Anti-inflammatory Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-inflammatory Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Anti-inflammatory Therapeutics Market Segment Percentages, by Type, 2022 (%)
- Anti-inflammatory Biologics
- Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
- Corticosteroids
- Others
Global Anti-inflammatory Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Anti-inflammatory Therapeutics Market Segment Percentages, by Application, 2022 (%)
- Arthritis
- Respiratory Diseases
- Dermatology
- Gastroenterology
- Others
Global Anti-inflammatory Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Anti-inflammatory Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Anti-inflammatory Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Anti-inflammatory Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AbbVie
- Johnson & Johnson
- Amgen Inc
- AstraZeneca PLC
- Pfizer, Inc
- Novartis
- Roche
- Merck
- Sanofi
- GlaxoSmithKline
- Sun Pharmaceutical Industries Ltd
- TEVA
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Anti-inflammatory Therapeutics, market overview.
- Chapter 2: Global Anti-inflammatory Therapeutics market size in revenue.
- Chapter 3: Detailed analysis of Anti-inflammatory Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Anti-inflammatory Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anti-inflammatory Therapeutics Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 113740 million
|
| Forecast Market size by 2029 |
US$ 169200 million
|
| Growth Rate |
CAGR of 5.8% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-inflammatory Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-inflammatory Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-inflammatory Therapeutics Overall Market Size
2.1 Global Anti-inflammatory Therapeutics Market Size: 2022 VS 2029
2.2 Global Anti-inflammatory Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-inflammatory Therapeutics Players in Global Market
3.2 Top Global Anti-inflammatory Therapeutics Companies Ranked by Revenue
3.3 Global Anti-inflammatory Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Anti-inflammatory Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti-inflammatory Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-inflammatory Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Anti-inflammatory Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-inflammatory Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-inflammatory Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Anti-inflammatory Biologics
4.1.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
4.1.4 Corticosteroids
4.1.5 Others
4.2 By Type - Global Anti-inflammatory Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Anti-inflammatory Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Anti-inflammatory Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Anti-inflammatory Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-inflammatory Therapeutics Market Size, 2022 & 2029
5.1.2 Arthritis
5.1.3 Respiratory Diseases
5.1.4 Dermatology
5.1.5 Gastroenterology
5.1.6 Others
5.2 By Application - Global Anti-inflammatory Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Anti-inflammatory Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Anti-inflammatory Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Anti-inflammatory Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-inflammatory Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Anti-inflammatory Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Anti-inflammatory Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Anti-inflammatory Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Anti-inflammatory Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Anti-inflammatory Therapeutics Revenue, 2018-2029
6.3.2 US Anti-inflammatory Therapeutics Market Size, 2018-2029
6.3.3 Canada Anti-inflammatory Therapeutics Market Size, 2018-2029
6.3.4 Mexico Anti-inflammatory Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Anti-inflammatory Therapeutics Revenue, 2018-2029
6.4.2 Germany Anti-inflammatory Therapeutics Market Size, 2018-2029
6.4.3 France Anti-inflammatory Therapeutics Market Size, 2018-2029
6.4.4 U.K. Anti-inflammatory Therapeutics Market Size, 2018-2029
6.4.5 Italy Anti-inflammatory Therapeutics Market Size, 2018-2029
6.4.6 Russia Anti-inflammatory Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Anti-inflammatory Therapeutics Market Size, 2018-2029
6.4.8 Benelux Anti-inflammatory Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Anti-inflammatory Therapeutics Revenue, 2018-2029
6.5.2 China Anti-inflammatory Therapeutics Market Size, 2018-2029
6.5.3 Japan Anti-inflammatory Therapeutics Market Size, 2018-2029
6.5.4 South Korea Anti-inflammatory Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Anti-inflammatory Therapeutics Market Size, 2018-2029
6.5.6 India Anti-inflammatory Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Anti-inflammatory Therapeutics Revenue, 2018-2029
6.6.2 Brazil Anti-inflammatory Therapeutics Market Size, 2018-2029
6.6.3 Argentina Anti-inflammatory Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-inflammatory Therapeutics Revenue, 2018-2029
6.7.2 Turkey Anti-inflammatory Therapeutics Market Size, 2018-2029
6.7.3 Israel Anti-inflammatory Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Anti-inflammatory Therapeutics Market Size, 2018-2029
6.7.5 UAE Anti-inflammatory Therapeutics Market Size, 2018-2029
7 Anti-inflammatory Therapeutics Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Anti-inflammatory Therapeutics Major Product Offerings
7.1.4 AbbVie Anti-inflammatory Therapeutics Revenue in Global Market (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Major Product Offerings
7.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Amgen Inc
7.3.1 Amgen Inc Company Summary
7.3.2 Amgen Inc Business Overview
7.3.3 Amgen Inc Anti-inflammatory Therapeutics Major Product Offerings
7.3.4 Amgen Inc Anti-inflammatory Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Amgen Inc Key News & Latest Developments
7.4 AstraZeneca PLC
7.4.1 AstraZeneca PLC Company Summary
7.4.2 AstraZeneca PLC Business Overview
7.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Major Product Offerings
7.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue in Global Market (2018-2023)
7.4.5 AstraZeneca PLC Key News & Latest Developments
7.5 Pfizer, Inc
7.5.1 Pfizer, Inc Company Summary
7.5.2 Pfizer, Inc Business Overview
7.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Major Product Offerings
7.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Pfizer, Inc Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Anti-inflammatory Therapeutics Major Product Offerings
7.6.4 Novartis Anti-inflammatory Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Roche
7.7.1 Roche Company Summary
7.7.2 Roche Business Overview
7.7.3 Roche Anti-inflammatory Therapeutics Major Product Offerings
7.7.4 Roche Anti-inflammatory Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Roche Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Anti-inflammatory Therapeutics Major Product Offerings
7.8.4 Merck Anti-inflammatory Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Anti-inflammatory Therapeutics Major Product Offerings
7.9.4 Sanofi Anti-inflammatory Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Company Summary
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Major Product Offerings
7.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue in Global Market (2018-2023)
7.10.5 GlaxoSmithKline Key News & Latest Developments
7.11 Sun Pharmaceutical Industries Ltd
7.11.1 Sun Pharmaceutical Industries Ltd Company Summary
7.11.2 Sun Pharmaceutical Industries Ltd Business Overview
7.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Major Product Offerings
7.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue in Global Market (2018-2023)
7.11.5 Sun Pharmaceutical Industries Ltd Key News & Latest Developments
7.12 TEVA
7.12.1 TEVA Company Summary
7.12.2 TEVA Business Overview
7.12.3 TEVA Anti-inflammatory Therapeutics Major Product Offerings
7.12.4 TEVA Anti-inflammatory Therapeutics Revenue in Global Market (2018-2023)
7.12.5 TEVA Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti-inflammatory Therapeutics Market Opportunities & Trends in Global Market
Table 2. Anti-inflammatory Therapeutics Market Drivers in Global Market
Table 3. Anti-inflammatory Therapeutics Market Restraints in Global Market
Table 4. Key Players of Anti-inflammatory Therapeutics in Global Market
Table 5. Top Anti-inflammatory Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anti-inflammatory Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anti-inflammatory Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anti-inflammatory Therapeutics Product Type
Table 9. List of Global Tier 1 Anti-inflammatory Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-inflammatory Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Anti-inflammatory Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anti-inflammatory Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Anti-inflammatory Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anti-inflammatory Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Anti-inflammatory Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anti-inflammatory Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. AbbVie Company Summary
Table 31. AbbVie Anti-inflammatory Therapeutics Product Offerings
Table 32. AbbVie Anti-inflammatory Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. AbbVie Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson Anti-inflammatory Therapeutics Product Offerings
Table 36. Johnson & Johnson Anti-inflammatory Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. Amgen Inc Company Summary
Table 39. Amgen Inc Anti-inflammatory Therapeutics Product Offerings
Table 40. Amgen Inc Anti-inflammatory Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Amgen Inc Key News & Latest Developments
Table 42. AstraZeneca PLC Company Summary
Table 43. AstraZeneca PLC Anti-inflammatory Therapeutics Product Offerings
Table 44. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. AstraZeneca PLC Key News & Latest Developments
Table 46. Pfizer, Inc Company Summary
Table 47. Pfizer, Inc Anti-inflammatory Therapeutics Product Offerings
Table 48. Pfizer, Inc Anti-inflammatory Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer, Inc Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Anti-inflammatory Therapeutics Product Offerings
Table 52. Novartis Anti-inflammatory Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Anti-inflammatory Therapeutics Product Offerings
Table 56. Roche Anti-inflammatory Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Anti-inflammatory Therapeutics Product Offerings
Table 60. Merck Anti-inflammatory Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Merck Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Anti-inflammatory Therapeutics Product Offerings
Table 64. Sanofi Anti-inflammatory Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Sanofi Key News & Latest Developments
Table 66. GlaxoSmithKline Company Summary
Table 67. GlaxoSmithKline Anti-inflammatory Therapeutics Product Offerings
Table 68. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. GlaxoSmithKline Key News & Latest Developments
Table 70. Sun Pharmaceutical Industries Ltd Company Summary
Table 71. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Offerings
Table 72. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 73. Sun Pharmaceutical Industries Ltd Key News & Latest Developments
Table 74. TEVA Company Summary
Table 75. TEVA Anti-inflammatory Therapeutics Product Offerings
Table 76. TEVA Anti-inflammatory Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 77. TEVA Key News & Latest Developments
List of Figures
Figure 1. Anti-inflammatory Therapeutics Segment by Type in 2022
Figure 2. Anti-inflammatory Therapeutics Segment by Application in 2022
Figure 3. Global Anti-inflammatory Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-inflammatory Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-inflammatory Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-inflammatory Therapeutics Revenue in 2022
Figure 8. By Type - Global Anti-inflammatory Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Anti-inflammatory Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Anti-inflammatory Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Anti-inflammatory Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Anti-inflammatory Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Anti-inflammatory Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Anti-inflammatory Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Anti-inflammatory Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Anti-inflammatory Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Anti-inflammatory Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. AbbVie Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Amgen Inc Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer, Inc Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Roche Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Merck Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sanofi Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. TEVA Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
